One should not forget that taurine is already used as a medicine in humans. Against mitochondrial diseases and heart failure, and taurine also has many other beneficial physiological effects on humans. The taurine related effects on the cardiovascular system are especially interesting. For instance, on the heart and also the Antithrombotic potential. I think that the vast human data on the effects that Taurine show on human physiological systems (and diseases) in part is a counterargument against karls position against the recent study about taurines potential as an agent that might increase human healthspan/lifespan. I really like the extensive research on Taurine that is done on the human physiology.
”Nowadays, there is overwhelming evidence about the involvement of taurine in fundamental physiological processes, such as neuromodulation, bile acid conjugation, intestinal microbiota homeostasis, regulation of energy metabolism, muscle contraction, ion transport, calcium handling, immunomodulation, anti-inflammatory and anti-oxidative response, osmoregulation, and cell membrane stabilization and apoptosis [3,4,9,10,11]. Taurine has been further proved to exert many pharmacologic actions, acting as a protective agent against pathologies including nervous diseases (retinal degeneration, stroke, neurodegenerative diseases—Parkinson’s, Alzheimer’s, or Huntington’s disease—epilepsy, fragile X syndrome, succinic semialdehyde dehydrogenase deficiency), metabolic diseases (diabetes mellitus, stroke-like episodes - MELAS, mitochondrial disease), inflammatory diseases, sarcopenia, myotonic dystrophy, and Duchenne muscular dystrophy [9,10,11]. Moreover, taurine elicits protection against cardiovascular disease [5,9,12,13,14], delaying the progression of atherosclerosis [15,16], reducing blood pressure [17,18,19,20], preventing the development and correcting cardiomyopathy [21,22,23,24,25,26], showing efficacy in ischemia-reperfusion injury [9,27], manifesting antiarrhythmic properties, preventing sudden death [28,29,30,31,32], and acting as a cardioprotective agent in congestive heart failure (CHF) [11,33]. As a matter of fact, taurine has been approved to be included in the treatment of CHF in Japan [9]. Generally, no side effects of taurine administration have been reported at regular doses, nor major ones at high doses (over 6 g/day) [8,11,33,34,35,36]. Through all these above mentioned actions, taurine can represent an important future component of the newer promising therapies against cardiovascular disease.
Last but not least, taurine has been proven to manifest inhibitory effects on key processes of hemostasis, such as platelet activation and aggregation. Our descriptive article aims to review available data regarding the influence of taurine and its derivatives on platelet function, focusing on its claimed antithrombotic potential.”